StockData
Ocugen, Inc. logo

Ocugen, Inc. (OCGN) stock

OCGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$0.74−0.02 (-2.31%)

Close on Nov 18, 2026Market cap $250.67MP/E –Yield –

Ocugen operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Ocugen's operating income for the twelve months ending Jun 30, 2026 was -$68.90M. For fiscal 2025 it was -$62.92M. The highest annual figure on record is -$14.16M in fiscal 2019.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$62.92M–
FY2024Dec 31, 2024-$54.76M–
FY2023Dec 31, 2023-$65.53M–
FY2022Dec 31, 2022-$89.07M–
FY2021Dec 31, 2021-$58.03M–
FY2020Dec 31, 2020-$21.29M–
FY2019Dec 31, 2019-$14.16M–
FY2018Dec 31, 2018-$16.14M–
FY2017Dec 31, 2017-$24.95M–
FY2016Dec 31, 2016-$30.31M–
FY2015Dec 31, 2015-$31.82M–
FY2014Dec 31, 2014-$32.66M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$16.44M–
Q1 FY2026Mar 31, 2026-$17.84M–
Q4 FY2025Dec 31, 2025-$17.00M–
Q3 FY2025Sep 30, 2025-$17.63M–
Q2 FY2025Jun 30, 2025-$13.80M–
Q1 FY2025Mar 31, 2025-$14.50M–
Q4 FY2024Dec 31, 2024-$13.84M–
Q3 FY2024Sep 30, 2024-$13.25M–
Q2 FY2024Jun 30, 2024-$15.45M–
Q1 FY2024Mar 31, 2024-$12.22M–
Q4 FY2023Dec 31, 2023-$11.53M–
Q3 FY2023Sep 30, 2023-$12.43M–
Q2 FY2023Jun 30, 2023-$23.54M–
Q1 FY2023Mar 31, 2023-$18.04M–
Q4 FY2022Dec 31, 2022-$23.36M–
Q3 FY2022Sep 30, 2022-$25.11M–
Q2 FY2022Jun 30, 2022-$21.58M–
Q1 FY2022Mar 31, 2022-$19.03M–
Q4 FY2021Dec 31, 2021-$14.57M–
Q3 FY2021Sep 30, 2021-$10.79M–
Q2 FY2021Jun 30, 2021-$25.61M–
Q1 FY2021Mar 31, 2021-$7.06M–
Q4 FY2020Dec 31, 2020-$3.81M–
Q3 FY2020Sep 30, 2020-$10.18M–
Q2 FY2020Jun 30, 2020-$3.37M–
Q1 FY2020Mar 31, 2020-$3.93M–
Q4 FY2019Dec 31, 2019-$4.28M–
Q3 FY2019Sep 30, 2019-$2.71M–
Q2 FY2019Jun 30, 2019-$2.33M–
Q1 FY2019Mar 31, 2019-$4.84M–
Q4 FY2018Dec 31, 2018-$5.69M–
Q3 FY2018Sep 30, 2018-$2.40M–
Q2 FY2018Jun 30, 2018-$7.28M–
Q1 FY2018Mar 31, 2018-$6.09M–
Q4 FY2017Dec 31, 2017-$6.03M–
Q3 FY2017Sep 30, 2017-$5.71M–
Q2 FY2017Jun 30, 2017-$6.37M–
Q1 FY2017Mar 31, 2017-$6.83M–
Q4 FY2016Dec 31, 2016-$7.91M–
Q3 FY2016Sep 30, 2016-$6.65M–

More Ocugen figures

See a number that looks wrong?